Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.
Monson NL, Cravens P, Hussain R, Harp CT, Cummings M, de Pilar Martin M, Ben LH, Do J, Lyons JA, Lovette-Racke A, Cross AH, Racke MK, Stüve O, Shlomchik M, Eagar TN.
Monson NL, et al.
PLoS One. 2011 Feb 16;6(2):e17103. doi: 10.1371/journal.pone.0017103.
PLoS One. 2011.
PMID: 21359213
Free PMC article.